SEC Form 4 · accession 0001062359-16-000002

RenovaCare, Inc. · RCAR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

10% Owner

Period of report

Feb 2, 2016

Accepted (ET)

Feb 3, 2016 · 2:58 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001016708

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common stock, par value $0.00001^F2,F3	Feb 2, 2016	P	2,173,913	$0.46	A	44,550,713	I	Kalen Capital Corporation

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series B Stock Purchase Warrant^F5,F2,F4	$0.46	Feb 2, 2016	C	2,173,913	D	Nov 29, 2013	Nov 29, 2018	Common stock, par value $0.00001	1,326,087	5,626,087	I

F1On February 2, 2016, Kalen Capital Corporation exercised a Series B Stock Purchase Warrant for 2,173,913 shares of Issuers common stock at an exercise price of $0.46 per share for payment of $999,999.98.
F2Does not include derivative securities beneficially owned by Mr. Rayat.
F3Mr. Rayat is the sole shareholder and sole director of Kalen Capital Corporation.
F4Represents the number of shares remaining issuable upon exercise of the Series B Stock Purchase Warrant.
F5Includes (a) a Series B Stock Purchase Warrant to purchase up to 1,326,087 shares of the Issuers common stock at an exercise price of $0.46 per share through November 29, 2018; (b) a Series C Stock Purchase Warrant to purchase up to 3,500,000 shares of the Issuers common stock at an exercise price of $0.49 per share through November 29, 2018; and (c) a Series D Stock Purchase Warrant to purchase up to 800,000 shares of the Issuers common stock at an exercise price of $1.10 per share through June 5, 2020. Each of the foregoing warrants may be exercised on a cashless basis.